UGRO Capital Limited has announced the allotment of unlisted commercial papers worth Rs 20 crores. The Investment and Borrowing Committee of the Board of Directors approved this issuance on February 26, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Commercial Paper Details

The commercial papers feature specific terms and conditions designed for short-term funding requirements. Each security carries a face value of Rs 5,00,000 with an issue price of Rs 4,89,381 per security.

Financial Structure

The total issue value amounts to Rs 19,57,52,400, while the redemption value is set at Rs 20,00,00,000. This structure reflects the discount pricing typical of commercial paper instruments, where investors purchase at a discount and receive the full face value at maturity.

Regulatory Compliance

The company has fulfilled its disclosure obligations under SEBI regulations by informing both BSE Limited and National Stock Exchange of India Limited about this allotment. The information has been made available on the company's official website at www.ugrocapital.com for stakeholder access.

The commercial papers represent a short-term debt instrument that will mature in 90 days from the allotment date, providing the company with immediate capital while offering investors a fixed-term investment opportunity with Yes Bank Limited serving as the designated Issue and Paying Agent.

UGRO Capital Limited has secured a significant regulatory milestone in its corporate restructuring initiative, receiving the Reserve Bank of India's 'No Objection' for its proposed amalgamation with wholly owned subsidiary Profectus Capital Private Limited. The approval marks a crucial step forward in the company's consolidation strategy.

RBI Approval Details

The Reserve Bank of India granted its 'No Objection' to the Scheme of Amalgamation through a letter dated February 25, 2026. The approval comes with stipulated conditions that the company must fulfill as part of the merger process.

Board Approval and Timeline

The amalgamation scheme received initial approval from UGRO Capital's Board of Directors during a meeting held on January 8, 2026. Following the board's decision, the company promptly submitted its application to the RBI on January 9, 2026, demonstrating efficient execution of the regulatory approval process.

Regulatory Compliance Framework

As part of the comprehensive approval process, UGRO Capital has applied to stock exchanges for observation letters under Regulations 37 and 59A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This step ensures compliance with securities market regulations governing corporate amalgamations.

Pending Approvals

Despite receiving RBI's 'No Objection', the scheme remains subject to several additional approvals:

• National Company Law Tribunal approval
• Consent from other applicable regulatory authorities
• Approval from shareholders of both companies
• Creditor approvals as required under applicable laws

The company has made the disclosure information available on its official website at www.ugrocapital.com , ensuring transparency and stakeholder accessibility to relevant documentation.